menu
    • menu

    Company profile for Apertura Gene Therapy

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Apertura is a biotechnology company opening opportunities for treating debilitating diseases with limited options. We are uniquely positioned to develop genetic medicines by simultaneously engineering AAV capsids, regulatory elements, and payloads to overcome current limitations in gene therapy. Apertura is committed to growing the field of gene therapy and believes that together we maximize our impact by working with corporat...
    Apertura is a biotechnology company opening opportunities for treating debilitating diseases with limited options. We are uniquely positioned to develop genetic medicines by simultaneously engineering AAV capsids, regulatory elements, and payloads to overcome current limitations in gene therapy. Apertura is committed to growing the field of gene therapy and believes that together we maximize our impact by working with corporate and academic collaborators, patients, and disease foundations.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Apertura Gene TherapyUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    345 Park Ave South Floor 6 New York, NY 10010
    Telephone
    Telephone
    555.918.8251
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://aperturagtx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/apertura-gene-therapy/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/Apertura_GTX

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Apertura Gene Therapy Launches Open Aperture
    Apertura Gene Therapy Launches Open Aperture

    12 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/apertura-gene-therapy-launches-open-aperture-a-material-transfer-agreement-program-to-facilitate-non-commercial-access-to-tfr1-capx-for-academic-researchers-302686400.html

    PR NEWSWIRE
    12 Feb 2026
    Share Share
    Apertura Licenses AAV Capsid for CNS Treatments
    Apertura Licenses AAV Capsid for CNS Treatments

    13 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/apertura-gene-therapy-licenses-blood-brain-barrier-penetrant-aav-capsid-to-multiple-partners-advancing-central-nervous-system-treatments-302528411.html

    PR NEWSWIRE
    13 Aug 2025
    Share Share
    Apertura, RSRT Partner on Rett Gene Therapy
    Apertura, RSRT Partner on Rett Gene Therapy

    30 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/30/3071236/0/en/Apertura-Gene-Therapy-and-Rett-Syndrome-Research-Trust-Collaborate-to-Pioneer-Advanced-Genetic-Medicines-for-Rett-Syndrome-Using-TfR1-Targeted-AAV-Capsid.html

    GLOBENEWSWIRE
    30 Apr 2025
    Share Share
    Apertura Capsid Engineering Platform At ASGCT 2024
    Apertura Capsid Engineering Platform At ASGCT 2024

    10 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/10/2879536/0/en/Apertura-Gene-Therapy-Showcases-Advancements-in-Capsid-Engineering-Platform-in-Presentations-at-ASGCT-Annual-Meeting.html

    GLOBENEWSWIRE
    10 May 2024
    Share Share
    Apertura Gene Therapy Unveils Novel Engineered AAV Capsids
    Apertura Gene Therapy Unveils Novel Engineered AAV Capsids

    04 Jan 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240104444092/en

    BUSINESSWIRE
    04 Jan 2024
    Share Share
    Apertura Gene Therapy Announces Scientific Founder Presentations on AAV Capsid
    Apertura Gene Therapy Announces Scientific Founder Presentations on AAV Capsid

    03 May 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230503005335/en

    BUSINESSWIRE
    03 May 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search